Big scoop: health ministers in EU’s pharma powers Germany,France,Italy & Netherlands joined forces to obtain vaccines for the bloc (kinda nascent EU Op Warpspeed) but their leaders forced them to abdicate responsibility to the Commission, which then failed to get enough doses 1/3 https://twitter.com/bild/status/1346068135431049216
This is the letter sent by the healthcare minister to the Commission, drafted in slightly apologetic tone, asking the EU executive to take over vaccine procurement. Result: the EU, pop 450m, is now stuck with mere 200m BioNTech-Pfizer and 80m Moderna jabs by the autumn (at best).
Meanwhile, the new coronavirus variant that has spread from Britain could make obtaining herd immunity more difficult: as many as 80% of the population might need to be immunised to halt the pandemic https://www.wsj.com/articles/covid-19-variant-could-make-herd-immunity-more-difficult-says-biontech-11608646717?st=9pi5ust16wnoyut&reflink=article_copyURL_share
Germany and Denmark could follow UK leadership in delaying the second dose of the covid vaccines https://www.theguardian.com/world/2021/jan/04/germany-denmark-second-dose-covid-vaccine
On November 11, when it was clear that vaccine by @BioNTech_Group & @pfizer was the market leader, the EU ordered 200m doses, with an option for another 100m. On November 17 the EU ordered 400m from CureVac, a German company that hadn’t even started phase 3 trial. Why?